BioNeutra Global Corporation
BGACFOTCConsumer Defensive● Active
$0.01
+$0.00(+0.00%)
Market Cap$260113
P/E Ratio—
52W High$0.067
52W Low$0.0056
BioNeutra Global Corporation (BGACF) · Income Statement
Annual, quarterly, or TTM views · SEC 10-K & 10-Q via FMP · adjust period and M/B/T below.
FMP · BGACF · as of 2026-06-09
Financial statements
Revenue · Gross Profit · Net Income
| Breakdown | 2023-12 | 2022-12 | 2021-12 | 2020-12 | 2019-12 |
|---|---|---|---|---|---|
| Revenue | |||||
| Revenue | $11.38M | $13.39M | $15.40M | $24.12M | $37.70M |
| Cost of Revenue | $7.24M | $11.04M | $12.51M | $20.17M | $37.06M |
| Gross Profit | $4.14M | $2.35M | $2.89M | $3.94M | $0.64M |
| Gross Margin %(computed) | 36.40% | 17.53% | 18.77% | 16.35% | 1.69% |
| Operating Expenses | |||||
| R&D Expenses | $0.15M | ($0.02M) | $0.01M | $0.26M | $0.44M |
| G&A Expenses | $3.73M | $3.78M | $3.73M | $3.96M | $8.38M |
| Total Operating Expenses | $5.58M | $4.82M | $5.25M | $6.97M | $8.58M |
| Operating Income | ($1.44M) | ($2.42M) | ($2.35M) | ($3.03M) | ($9.83M) |
| Operating Margin %(computed) | -12.63% | -18.06% | -15.29% | -12.55% | -26.08% |
| Interest Income | $0.12M | $0.00M | $0.00M | $0.00M | $0.00M |
| Interest Expense | $0.70M | $0.45M | $0.39M | $0.43M | $0.60M |
| Income Before Tax | ($2.11M) | ($2.92M) | ($2.83M) | ($3.77M) | ($13.02M) |
| Income Tax Expense | $0.00M | $0.00M | $0.00M | ($0.06M) | ($0.58M) |
| Net Income | ($2.11M) | ($2.92M) | ($2.83M) | ($3.71M) | ($12.44M) |
| Net Margin %(computed) | -18.52% | -21.81% | -18.38% | -15.37% | -33.00% |
| Per Share & EBITDA | |||||
| EPS (Basic) | $-0.05 | $-0.06 | $-0.06 | $-0.08 | $-0.27 |
| Wtd Avg Shares | 46.45M | 46.45M | 46.45M | 46.45M | 46.45M |
| EBITDA | ($0.35M) | ($1.36M) | ($1.11M) | ($1.50M) | ($10.10M) |
| EBITDA Margin %(computed) | -3.09% | -10.16% | -7.24% | -6.21% | -26.79% |
Data source: Financial Modeling Prep · Last updated: 2026-06-09 · CAD · M
Explore more BioNeutra Global Corporation data
About BioNeutra Global Corporation (BGACF) Income Statement
BioNeutra Global Corporation (BGACF) income statement data is sourced from SEC Form 10-K and 10-Q filings. For fiscal year 2023, BGACF reported revenue of $0.01B, gross profit of $0.00B (gross margin 36.40%), and net income of ($0.00B) — a net profit margin of -18.52%.
Frequently asked questions
BGACF · 4 questionsBioNeutra Global Corporation (BGACF) reported revenue of $0.01B for 2023, down 15.0% year-over-year.
BGACF revenueBGACF salesannual revenue YoYincome statement
· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09